1. Doctors Spending in Excess of
$32,000 on Health IT
Doctors are spending more than
$32,000 per year on health information technology (IT), according to an article
published in Medical Economics. Results from the Medical Group Management
Association (MGMA) survey suggest that medical groups spend more than $32,500
per year for every full-time doctor in their practice. Multisite practices
incur additional costs for salaries of IT support staff and equipment,
maintenance, and supplies. Between 2009 and 2015, costs for IT increased by 40
percent, with the biggest increases seen in 2010 and 2011; costs can be
expected to continue increasing at considerable rates. IT plays a crucial role
in helping health care organizations to evolve in order to provide higher
quality, value-based care, and physicians are looking to use technology to
improve practice management and to avoid government meaningful use penalties. http://medicalxpress.com/news/2016-10-doctors-excess-health.html
2. New Drug Target for Asthma,
Autoimmune Disorders Identified
Using a new tool for probing the
molecular makeup of cells, researchers have discovered that PD-1 - a marker
that already serves as a drug target for some cancers - may also serve as a
drug target for asthma and other autoimmune disorders. The researchers, led by
a group from the Wellcome Trust Sanger Institute in the United Kingdom, report
their work in the journal Nature. In the new study, the researchers examine a
recently discovered group of cells in the immune system called innate lymphoid
cells (ILC cells). Within this group, there is a subgroup called ILC2 cells
that influences immune responses during infections and asthma. http://www.medicalnewstoday.com/articles/313263.php
3. A Stem Cell Gene Found to Command
Skeletal Muscle Regeneration
Prox1 gene has long been known to
play an important role in fetal development. Finnish researchers have now
discovered that Prox1 is essential also for skeletal muscle stem cell
differentiation. Skeletal muscles are important not only for locomotion but also
for the regulation of whole-body metabolism. Muscles have remarkable capacity
to regenerate after injury and to adapt in response to exercise training.
Researchers from Wihuri Research Institute and the University of Helsinki,
Finland, have now found that skeletal muscle stem cells called satellite cells
also express the Prox1 gene. The new surprising results of the study, published
in Nature Communications, show that satellite cells differentiate into
myofibres only when Prox1 is active. https://www.sciencedaily.com/releases/2016/10/161012095822.htm
4. G.O.P. Plans to Replace Health
Care Law with ‘Universal Access’
House Republicans, responding to
criticism that repealing the Affordable Care Act would leave millions without
health insurance, said that their goal in replacing President Obama’s health
law was to guarantee “universal access” to health care and coverage, not
necessarily to ensure that everyone actually has insurance. In defending the
Affordable Care Act, the Obama administration, congressional Democrats and
advocacy groups have focused on the 20 million people covered by the law, which
has pushed the percentage of Americans without health insurance to record lows.
The American Medical Association recently said that “any new reform proposal
should not cause individuals currently covered to become uninsured.” http://nyti.ms/2hU5WIm
5. Harnessing the U.S. Taxpayer to
Fight Cancer and Make Profits
Dr. Belldegrun, a physician,
co-founded Kite Pharma, a company that could be the first to market next year
with a highly anticipated new immunotherapy treatment. But even without a
product, Dr. Belldegrun has struck gold. His stock in Kite is worth about $170
million. Investors have profited along with him, as the company’s share price
has soared to about $50 from an initial price of $17 in 2014. The results
reflect widespread excitement over immunotherapy, which harnesses the body’s immune
system to attack cancer and has rescued some patients from near-certain death.
But they also speak volumes about the value of Kite’s main scientific partner: The
United States government.
http://www.nytimes.com/2016/12/19/health/harnessing-the-us-taxpayer-to-fight-cancer-and-make-profits.html
6. States Sue Generic-Drug Companies
over Price-Fixing Allegations
Twenty state attorneys general sued
a group of generic-drug companies Thursday, accusing them of colluding to fix
prices on an antibiotic and a diabetes medication, in violation of federal
antitrust law. The suit comes a day after price-fixing charges against former
executives at one of the drug makers were unsealed in a Justice Department
antitrust probe. The attorneys general, including Connecticut’s George Jepsen
and New York’s Eric Schneiderman, alleged in a suit filed in Connecticut
federal court that six companies conspired to manipulate prices for doxycycline
hyclate, an antibiotic, and glyburide, used in the treatment of diabetes. http://www.wsj.com/articles/states-sue-generic-drug-companies-over-price-fixing-allegations-1481820123
7. U.S. Health Spending in 2015
Averaged Nearly $10,000 per Person
Total spending on health care in the
United States increased last year at the fastest rate since the 2008 recession,
reaching $3.2 trillion, or an average of nearly $10,000 a person, the
Department of Health and Human Services reported. The growth coincided with
continuing increases in the number of Americans with insurance coverage,
through private health plans or Medicaid. Federal spending on health care has
increased by 21 percent over the past two years, as millions of Americans gained
coverage through the Affordable Care Act, the department said in its annual
report on health spending. http://nyti.ms/2gvMB2y